Literature DB >> 23057413

Carbohydrate recognition by the antiviral lectin cyanovirin-N.

Yukiji K Fujimoto1, David F Green.   

Abstract

Cyanovirin-N (CVN) is a cyanobacterial lectin with potent antiviral activity and has been the focus of extensive preclinical investigation as a potential prophylactic for the prevention of the sexual transmission of the human immunodeficiency virus (HIV). Here we present a detailed analysis of carbohydrate recognition by this important protein, using a combination of computational methods, including extensive molecular dynamics simulations and molecular mechanics/Poisson-Boltzmann surface area (MM/PBSA) energetic analysis. The simulation results strongly suggest that the observed tendency of wild-type CVN to form domain-swapped dimers is the result of a previously unidentified cis-peptide bond present in the monomeric state. The energetic analysis additionally indicates that the highest-affinity ligand for CVN characterized to date (α-Man-(1,2)-α-Man-(1,2)-α-Man) is recognized asymmetrically by the two binding sites. Finally, we are able to provide a detailed map of the role of all binding site functional groups (both backbone and side chain) to various aspects of molecular recognition: general affinity for cognate ligands, specificity for distinct oligosaccharide targets, and the asymmetric recognition of α-Man-(1,2)-α-Man-(1,2)-α-Man. Taken as a whole, these results complement past experimental characterization (both structural and thermodynamic) to provide the most complete understanding of carbohydrate recognition by CVN to date. The results also provide strong support for the application of similar approaches to the understanding of other protein-carbohydrate complexes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23057413      PMCID: PMC3531799          DOI: 10.1021/ja305755b

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  56 in total

1.  The domain-swapped dimer of cyanovirin-N is in a metastable folded state: reconciliation of X-ray and NMR structures.

Authors:  Laura G Barrientos; John M Louis; Istvan Botos; Toshiyuki Mori; Zhaozhong Han; Barry R O'Keefe; Michael R Boyd; Alexander Wlodawer; Angela M Gronenborn
Journal:  Structure       Date:  2002-05       Impact factor: 5.006

2.  Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping.

Authors:  F Yang; C A Bewley; J M Louis; K R Gustafson; M R Boyd; A M Gronenborn; G M Clore; A Wlodawer
Journal:  J Mol Biol       Date:  1999-05-07       Impact factor: 5.469

Review 3.  CHARMM: the biomolecular simulation program.

Authors:  B R Brooks; C L Brooks; A D Mackerell; L Nilsson; R J Petrella; B Roux; Y Won; G Archontis; C Bartels; S Boresch; A Caflisch; L Caves; Q Cui; A R Dinner; M Feig; S Fischer; J Gao; M Hodoscek; W Im; K Kuczera; T Lazaridis; J Ma; V Ovchinnikov; E Paci; R W Pastor; C B Post; J Z Pu; M Schaefer; B Tidor; R M Venable; H L Woodcock; X Wu; W Yang; D M York; M Karplus
Journal:  J Comput Chem       Date:  2009-07-30       Impact factor: 3.376

4.  De novo protein design: fully automated sequence selection.

Authors:  B I Dahiyat; S L Mayo
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

5.  Incorporation of the HIV-1 microbicide cyanovirin-N in a food product.

Authors:  Ming Li; Dorothy L Patton; Yvonne Cosgrove-Sweeney; Deena Ratner; Lisa C Rohan; Alexander M Cole; Patrick M Tarwater; Phalguni Gupta; Bharat Ramratnam
Journal:  J Acquir Immune Defic Syndr       Date:  2011-12-01       Impact factor: 3.731

6.  Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N.

Authors:  Donald F Smee; Kevin W Bailey; Min-Hui Wong; Barry R O'Keefe; Kirk R Gustafson; Vasiliy P Mishin; Larisa V Gubareva
Journal:  Antiviral Res       Date:  2008-07-02       Impact factor: 5.970

7.  Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques.

Authors:  Che-Chung Tsai; Peter Emau; Yonghou Jiang; Baoping Tian; William R Morton; Kirk R Gustafson; Michael R Boyd
Journal:  AIDS Res Hum Retroviruses       Date:  2003-07       Impact factor: 2.205

8.  Carbohydrate solution simulations: producing a force field with experimentally consistent primary alcohol rotational frequencies and populations.

Authors:  Michelle Kuttel; J W Brady; Kevin J Naidoo
Journal:  J Comput Chem       Date:  2002-10       Impact factor: 3.376

9.  Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus.

Authors:  L A Lagenaur; B E Sanders-Beer; B Brichacek; R Pal; X Liu; Y Liu; R Yu; D Venzon; P P Lee; D H Hamer
Journal:  Mucosal Immunol       Date:  2011-07-06       Impact factor: 7.313

10.  Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion.

Authors:  J Lifson; S Coutré; E Huang; E Engleman
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

View more
  5 in total

1.  Consensus design of a NOD receptor leucine rich repeat domain with binding affinity for a muramyl dipeptide, a bacterial cell wall fragment.

Authors:  Rachael Parker; Ana Mercedes-Camacho; Tijana Z Grove
Journal:  Protein Sci       Date:  2014-04-17       Impact factor: 6.725

2.  A flexible docking scheme efficiently captures the energetics of glycan-cyanovirin binding.

Authors:  Ashini Bolia; Brian W Woodrum; Angelo Cereda; Melissa A Ruben; Xu Wang; S Banu Ozkan; Giovanna Ghirlanda
Journal:  Biophys J       Date:  2014-03-04       Impact factor: 4.033

3.  Galactopyranoside-Substituted N-Heterocyclic Carbene Gold(I) Complexes: Synthesis, Stability, and Catalytic Applications to Alkyne Hydration.

Authors:  Ariana W Hobsteter; Mercedes A Badajoz; Marcos J Lo Fiego; Gustavo F Silbestri
Journal:  ACS Omega       Date:  2022-06-14

Review 4.  Complexity of Viral Epitope Surfaces as Evasive Targets for Vaccines and Therapeutic Antibodies.

Authors:  Nathaniel L Miller; Rahul Raman; Thomas Clark; Ram Sasisekharan
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

5.  A Designed "Nested" Dimer of Cyanovirin-N Increases Antiviral Activity.

Authors:  Brian W Woodrum; Jason Maxwell; Denysia M Allen; Jennifer Wilson; Lauren R H Krumpe; Andrey A Bobkov; R Blake Hill; Karen V Kibler; Barry R O'Keefe; Giovanna Ghirlanda
Journal:  Viruses       Date:  2016-06-06       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.